CG Oncology, led by Forbes 30 Under 30 alum Arhtur Kuan, has developed a genetically engineered virus to treat bladder cancer.
CG Oncology, led by Forbes 30 Under 30 alum Arhtur Kuan, has developed a genetically engineered virus to treat bladder cancer.